Ventus Therapeutics
Biotechnology Research • 
Waltham, Massachusetts, United States • 51-100 Employees
Company overview
| Headquarters | 100 Beaver St, Suite 202, Waltham, Massachusetts 02453, US |
| Phone number | +15143979517 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Founded | 2019 |
| Employees | 51-100 |
| Socials |
Key Contacts at Ventus Therapeutics
Markus Warmuth
Member Board Of Directors
Christopher Jenkins
Associate Director, Head Of It
Carole Gleeson
Sr. Director, New Product Planning & Portfolio Strategy
Sarah Williams
Director, Computer Aided Design
Pauline Sullivan
Senior Director Of Quality
Yelena Shuster-Rosen
Senior Director, Corporate Controller
Andre Matta
Executive Director
Heather Dowty
Senior Director
Tessa Forbes
Associate Director, Clinical Operations
Suzanne Nizza
Senior Director Of Business Operations
Ventus Therapeutics Email Formats
Ventus Therapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@ventustx.com), used 71% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@ventustx.com | 71% |
{first initial}{last name} | jdoe@ventustx.com | 29% |
About Ventus Therapeutics
At Ventus, we are pioneering a unique approach to structure-based drug discovery to address biologically validated, but difficult-to-drug targets. Others are building towards a future transformation of the drug development process … for Ventus, that future is already here. Our ReSOLVE™ platform integrates cutting-edge, structurally enabled, computational tools to identify and perfect new drug molecules for targets which have never been drugged or for which existing chemical matter leaves significant room for improvement. We are differentiated by our unique methods for modelling the properties of protein and water in motion. Optimal execution of these methods requires embedding our ReSOLVE platform with our world-class structural biology and chemistry teams. As our pipeline demonstrates, the ReSOLVE platform can find previously unknown pockets, better characterize known pockets, and solve the limitations of virtual screening, accelerating medicinal chemistry and structure-activity relationship (SAR) optimization. We are advancing a pipeline of new medicines to treat autoimmune and inflammatory diseases, neurological disorders, and cancer, and also generating a library of chemical matter for elusive targets for future pipeline needs and business development. Our team includes experienced biopharmaceutical executives, scientists who have delivered multiple approved medicines, and luminary academics spanning the fields of structural biology, immunology, and computational chemistry.
Ventus Therapeutics revenue & valuation
| Annual revenue | $29,000,000 |
| Revenue per employee | $363,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $92,800,000 |
| Total funding | $150,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Ventus Therapeutics has 35 employees across 12 departments.
Departments
Number of employees
Ventus Therapeutics Tech Stack
Discover the technologies and tools that power Ventus Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Security
Form builders
JavaScript frameworks
JavaScript libraries
Miscellaneous
Cookie compliance
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Miscellaneous
United Kingdom
Belgium
France
Poland
Gabon
Frequently asked questions
4.8
40,000 users
